117 related articles for article (PubMed ID: 8582114)
41. Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II.
Nakamura A; Iwao H; Fukui K; Kimura S; Tamaki T; Nakanishi S; Abe Y
Am J Physiol; 1990 Jan; 258(1 Pt 1):E1-6. PubMed ID: 2405694
[TBL] [Abstract][Full Text] [Related]
42. Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat.
Golin R; Pieruzzi F; Munforti C; Busca G; Di Blasio A; Zanchetti A
J Hypertens; 2001 Jul; 19(7):1271-7. PubMed ID: 11446717
[TBL] [Abstract][Full Text] [Related]
43. Transient Exposure of Enalapril Normalizes Prenatal Programming of Hypertension and Urinary Angiotensinogen Excretion.
Mansuri A; Elmaghrabi A; Legan SK; Gattineni J; Baum M
PLoS One; 2015; 10(12):e0146183. PubMed ID: 26719973
[TBL] [Abstract][Full Text] [Related]
44. Vasopeptidase inhibition has beneficial cardiac effects in spontaneously diabetic Goto-Kakizaki rats.
Grönholm T; Cheng ZJ; Palojoki E; Eriksson A; Bäcklund T; Vuolteenaho O; Finckenberg P; Laine M; Mervaala E; Tikkanen I
Eur J Pharmacol; 2005 Sep; 519(3):267-76. PubMed ID: 16137672
[TBL] [Abstract][Full Text] [Related]
45. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy.
Ishidoya S; Morrissey J; McCracken R; Klahr S
Kidney Int; 1996 Apr; 49(4):1110-9. PubMed ID: 8691732
[TBL] [Abstract][Full Text] [Related]
46. Effect of beta-adrenoceptor antagonist and angiotensin-converting enzyme inhibitor on hypertension-associated changes in adenylyl cyclase type V messenger RNA expression in spontaneously hypertensive rats.
Fujino T; Hasebe N; Kawabe J; Fujita M; Fukuzawa J; Tobise K; Kikuchi K
J Cardiovasc Pharmacol; 2003 May; 41(5):720-5. PubMed ID: 12717102
[TBL] [Abstract][Full Text] [Related]
47. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
De Gennaro Colonna V; Rossoni G; Rigamonti A; Bonomo S; Manfredi B; Berti F; Muller E
Eur J Pharmacol; 2002 Aug; 450(1):61-6. PubMed ID: 12176110
[TBL] [Abstract][Full Text] [Related]
48. Haemodynamic effects of dual blockade of the renin-angiotensin system in spontaneously hypertensive rats: influence of salt.
Richer-Giudicelli C; Domergue V; Gonzalez MF; Messadi E; Azizi M; Giudicelli JF; Ménard J
J Hypertens; 2004 Mar; 22(3):619-27. PubMed ID: 15076169
[TBL] [Abstract][Full Text] [Related]
49. Interaction of sodium loading and enalapril on renin mRNA and renin release in hydronephrotic mice.
Zhang YL; Wu JY; Wang XC; Liu L
Sheng Li Xue Bao; 2009 Jun; 61(3):239-46. PubMed ID: 19536436
[TBL] [Abstract][Full Text] [Related]
50. Dynamic changes of the renin-angiotensin and associated systems in the rat after pharmacological and dietary interventions in vivo.
Ochiai Y; Liang YQ; Serizawa M; Kato N
Physiol Genomics; 2008 Nov; 35(3):330-40. PubMed ID: 18796534
[TBL] [Abstract][Full Text] [Related]
51. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
Mizobuchi M; Morrissey J; Finch JL; Martin DR; Liapis H; Akizawa T; Slatopolsky E
J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
[TBL] [Abstract][Full Text] [Related]
52. Differential regulation of cathepsin B and prorenin gene expression in renal juxtaglomerular cells.
Todorov V; Müller M; Kurtz A
Kidney Blood Press Res; 2001; 24(2):75-8. PubMed ID: 11435737
[TBL] [Abstract][Full Text] [Related]
53. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
54. Coordinate changes of renin and brain-type nitric-oxide-synthase (b-NOS) mRNA levels in rat kidneys.
Schricker K; Pötzl B; Hamann M; Kurtz A
Pflugers Arch; 1996 Jul; 432(3):394-400. PubMed ID: 8765998
[TBL] [Abstract][Full Text] [Related]
55. [P21 expression in renal interstitial fibrosis and regulative effect of enalapril].
Xiao Y; Tao LJ; Damu T; Jin O; Zhou JH; Shen M; Hu J; Liu CY; Sun J; Ning WB
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):663-6, 670. PubMed ID: 17062926
[TBL] [Abstract][Full Text] [Related]
56. Renin enhancer is crucial for full response in Renin expression to an in vivo stimulus.
Markus MA; Goy C; Adams DJ; Lovicu FJ; Morris BJ
Hypertension; 2007 Nov; 50(5):933-8. PubMed ID: 17846348
[TBL] [Abstract][Full Text] [Related]
57. Normalisation of blood pressure in hypertensive TGR(mREN2)27 rats by amlodipine vs. enalapril: effects on cardiac hypertrophy and signal transduction pathways.
Witte K; Huser L; Knotter B; Heckmann M; Schiffer S; Lemmer B
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):101-9. PubMed ID: 11191827
[TBL] [Abstract][Full Text] [Related]
58. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II.
Schunkert H; Ingelfinger JR; Jacob H; Jackson B; Bouyounes B; Dzau VJ
Am J Physiol; 1992 Nov; 263(5 Pt 1):E863-9. PubMed ID: 1443118
[TBL] [Abstract][Full Text] [Related]
59. Cell and molecular studies of renin secretion.
Ice KS; Geary KM; Gomez RA; Johns DW; Peach MJ; Carey RM
Clin Exp Hypertens A; 1988; 10(6):1169-87. PubMed ID: 2852075
[TBL] [Abstract][Full Text] [Related]
60. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
Guo X; Wang J; Elimban V; Dhalla NS
Can J Physiol Pharmacol; 2008 Apr; 86(4):139-47. PubMed ID: 18418421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
